430 related articles for article (PubMed ID: 21167432)
1. [Pathology of cholangiocarcinoma].
Guedj N; Bedossa P; Paradis V
Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
4. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
5. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
9. [Classification and staging systems for hilar cholangio-carcinoma (Klatskin tumors): clinical application and practical relevance].
Gavrilovici V; Grecu F; Seripcariu V; Dragomir C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):412-7. PubMed ID: 21870733
[TBL] [Abstract][Full Text] [Related]
10. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
11. Sarcomatous cholangiocarcinoma.
Gupta K; Powari M; Dey P
Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
[No Abstract] [Full Text] [Related]
12. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of cholangiocarcinoma.
Jarnagin WR; Shoup M
Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
[TBL] [Abstract][Full Text] [Related]
14. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
15. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Study of Biliary Intraepithelial Neoplasia in Cholangiocarcinoma.
Kim HJ; Kim JS; Kim BH; Bak YT
Dig Surg; 2018; 35(2):116-120. PubMed ID: 28490009
[TBL] [Abstract][Full Text] [Related]
17. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]